End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
2017 | Neuron BioLabs, S.L. cancelled the acquisition of diagnostics operations, R&D services and patents of Alzheimer's disease from Neuron Bio, SA. | CI |
2017 | Neol Biosolutions Seeks Investors | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | - | |
Corporate Officer/Principal | 57 | - | |
Corporate Secretary | 67 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 79 | 05-12-18 | |
Director/Board Member | 67 | - | |
Director/Board Member | - | - | |
Director/Board Member | - | - | |
Director/Board Member | 75 | 19-01-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 15,611,366 | 13,569,480 ( 86.92 %) | 44,582 ( 0.2856 %) | 86.92 % |
Company contact information
Neuron Bio SA
P. T. S. Granada Calle Avenida de la Innovación No. 4
18016, Granada
+34 858 95 29 15
http://www.neuronbio.comGroup companies
Name | Category and Sector |
---|---|
Miscellaneous Commercial Services
|
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 5.19M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- NEU Stock
- Company Neuron Bio, S.A.